Thiogenesis Therapeutics Corp. (TTI : TSX-V)
Common Stock
$0.51
CAD
+0.01 (2.00%)
Last updated: 2026-08-21
Get TTI alerts:
TTI
Thiogenesis Therapeutics Corp.
WealthAwesomePerformance
1 Day
+2.00%
1 Week
-7.27%
1 Month
-7.27%
YTD
-21.54%
Key Statistics
Market Cap
$35.69M
52W High
$0.82
52W Low
$0.44
P/E Ratio
-
50 Day MA
$0.55
200 Day MA
$0.57
Beta
0.57
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 8/21/2026 | $0.51 | $0.52 | $0.51 | $0.51 | $0.51 | 30,000 |
| 8/20/2026 | $0.50 | $0.50 | $0.50 | $0.50 | $0.50 | 205,666 |
| 8/19/2026 | $0.58 | $0.58 | $0.55 | $0.55 | $0.55 | 50,500 |
| 8/14/2026 | $0.56 | $0.56 | $0.55 | $0.55 | $0.55 | 13,000 |
| 8/13/2026 | $0.57 | $0.57 | $0.57 | $0.57 | $0.57 | 28,000 |
| 8/11/2026 | $0.56 | $0.56 | $0.55 | $0.55 | $0.55 | 3,888 |
| 8/6/2026 | $0.55 | $0.55 | $0.55 | $0.55 | $0.55 | 10,000 |
| 7/29/2026 | $0.55 | $0.55 | $0.54 | $0.54 | $0.54 | 50,000 |
| 7/28/2026 | $0.57 | $0.57 | $0.57 | $0.57 | $0.57 | 1,000 |
| 7/27/2026 | $0.55 | $0.55 | $0.55 | $0.55 | $0.55 | 50,000 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TTI's historical volatility
30-Day Vol
55.4%
Annualized
90-Day Vol
61.7%
Annualized
Trend (90d)
-0.0%
Annualized drift
90d Mean
C$0.51
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.51 | C$0.42 – C$0.62 |
| 60 trading days | C$0.51 | C$0.39 – C$0.67 |
| 90 trading days | C$0.51 | C$0.37 – C$0.71 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Thiogenesis Therapeutics Corp.
Thiogenesis Therapeutics, Corp., a clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs. The company lead product candidate is TTI-0102, a prodrugs that consists of cysteamine for use in the treatment of mitochondrial encephalopathy lactic acidosis and stroke-like episodes, leigh syndrome, pediatric metabolic dysfunction-associated steatohepatitis, and nephropathic cystinosis. The company is headquartered in Toronto, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- -
- Profit Margin
- 0.00%
- ROE (TTM)
- -181.53%
- EPS (Diluted)
- -0.12
- Book Value
- 0.01
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About TTI
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| IRI | IEMR Resources Inc | $0.01 | +100.00% |
| PLY | Playfair Mining Ltd. | $0.09 | +63.64% |
| JADE | Jade Leader Corp | $0.01 | +50.00% |
| DELX | DelphX Capital Markets Inc | $0.01 | +50.00% |
| ATOM | Atomic Minerals Corp | $0.03 | +50.00% |
| GGAU | Galactic Gold Corp. | $0.19 | +35.71% |
| PTE | Pioneering Technology Corp | $0.02 | +33.33% |
| KIP | Kiplin Metals Inc | $0.27 | +32.50% |
TTI.V news timeline
1 article covering TTI.V, most recent first
Latest